[1] |
ABRAHAM E P, CHAIN E. An enzyme from bacteria able to destroy penicillin[J]. Nature, 1940, 146(3713):837.
|
[2] |
SU H C, YING G G, TAO R, et al. Class 1 and 2 integrons, sul resistance genes and antibiotic resistance in Escherichia coli isolated from Dongjiang River, South China[J]. Environ Pollut, 2012, 169:42-49.
|
[3] |
RUGGERONE P, MURAKAMI S, POS K M, et al. RND efflux pumps:structural information translated into function and inhibition mechanisms[J]. Curr Top Med Chem, 2013, 13(24):3079-3100.
|
[4] |
SULAVIK M C, HOUSEWEART C, CRAMER C, et al. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes[J]. Antimicrob Agents Chemother, 2001, 45(4):1126-1136.
|
[5] |
YUM S, XU Y B, PIAO S F, et al. Crystal structure of the periplasmic component of a tripartite macrolide-specific efflux pump[J]. J Mol Biol, 2009, 387(5):1286-1297.
|
[6] |
RAHMAN T, YARNALL B, DOYLE D A. Efflux drug transporters at the forefront of antimicrobial resistance[J]. Eur Biophys J, 2017, 46(7):647-653.
|
[7] |
RENAU T E, LÉGER R, FLAMME E M, et al. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin[J]. J Med Chem, 1999, 42(24):4928-4931.
|
[8] |
OPPERMAN T J, KWASNY S N, KIM H S, et al. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli[J]. Antimicrob Agents Chemother, 2014, 58(2):722-733.
|
[9] |
SJUTS H, VARGIU A V, KWASNY S M, et al. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives[J]. Proc Natl Acad Sci U S A, 2016, 113(13):3509-3514.
|
[10] |
Clinical and Laboratory Standards Institute. M 100-S28 performance standards for antimicrobial susceptibility testing; Twenty-second information supplement[S]. Wayne PA:CLSI, 2018.
|
[11] |
MARCHETTI O, MOREILLON P, GLAUSER M P, et al. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans[J]. Antimicrob Agents Chemother, 2000, 44(9):2373-2381.
|
[12] |
ODDS F C. Synergy, antagonism, and what the chequerboard puts between them[J]. J Antimicrob Chemother, 2003, 52(1):1.
|
[13] |
王印虎.以AcrB为靶标的小分子抑制剂的设计、合成及逆转耐药活性研究[D].泰安:山东大学, 2018.WANG Y H. Design, synthesis and reversal of bacterial resistance of small molecule inhibitor based on AcrB[D]. Tai'an:Shandong University, 2018.(in Chinese)
|
[14] |
贾泽,王春光,张石磊,等.赤芍水提物及芍药苷对大肠杆菌抗菌增敏活性的影响[J].中国兽医学报, 2019, 39(10):2026-2032.JIA Z, WANG C G, ZHANG S L, et al. Antibacterial and sensitizing activity of Paeonia lactiflora aqueous extract and paeoniflorin to Escherichia coli[J]. Chinese Journal of Veterinary Science, 2019, 39(10):2026-2032.(in Chinese)
|
[15] |
梁子英,刘芳.实时荧光定量PCR技术及其应用研究进展[J].现代农业科技, 2020(6):1-3, 8.LIANG Z Y, LIU F. Research progress on real-time quantitative PCR technology and its application[J]. Modern Agricultural Science and Technology, 2020(6):1-3, 8.(in Chinese)
|
[16] |
JORGENSEN W L. The many roles of computation in drug discovery[J]. Science, 2004, 303(5665):1813-1818.
|
[17] |
TROTT O, OLSON A J. AutoDock Vina:Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading[J]. J Comput Chem, 2010, 31(2):455-461.
|
[18] |
KINANA A D, VARGIU A V, MAY T, et al. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump[J]. Proc Natl Acad Sci U S A, 2016, 113(5):1405-1410.
|
[19] |
NAKASHIMA R, SAKURAI K, YAMASAKI S, et al. Structural basis for the inhibition of bacterial multidrug exporters[J]. Nature, 2013, 500(7460):102-106.
|
[20] |
POOLE K. Efflux-mediated multiresistance in Gram-negative bacteria[J]. Clin Microbiol Infect, 2004, 10(1):12-26.
|
[21] |
NISHINO K, YAMADA J, HIRAKAWA H, et al. Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to β-lactams[J]. Antimicrob Agents Chemother, 2003, 47(9):3030-3033.
|
[22] |
LÁZÁR V, PAL SINGH G, SPOHN R, et al. Bacterial evolution of antibiotic hypersensitivity[J]. Mol Syst Biol, 2013, 9(1):700.
|
[23] |
SCHUSTER S, BOHNERT J A, VAVRA M, et al. Proof of an outer membrane target of the efflux inhibitor Phe-Arg-β-naphthylamide from random mutagenesis[J]. Molecules, 2019, 24(3):470.
|
[24] |
FERRARI R G, GALIANA A, CREMADES R, et al. Expression of the marA, soxS, acrB and ramA genes related to the AcrAB/TolC efflux pump in Salmonella enterica strains with and without quinolone resistance-determining regions gyrA gene mutations[J]. J Infect Dis, 2013, 17(2):125-130.
|
[25] |
ZHENG J, CUI S H, MENG J H. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium[J]. J Antimicrob Chemother, 2008, 63(1):95-102.
|
[26] |
BAILEY A M, PAULSEN I T, PIDDOCK L J V. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, Which is inhibited by chlorpromazine[J]. Antimicrob Agents Chemother, 2008, 52(10):3604-3611.
|
[27] |
PIDDOCK L J V. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria[J]. Clin Microbiol Rev, 2006, 19(2):382-402.
|
[28] |
RAHMATI S, YANG S, DAVIDSON A L, et al. Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA[J]. Mol Microbiol, 2002, 43(3):677-685.
|
[29] |
MANJASETTY B A, HALAVATY A S, LUAN C H, et al. Loop-to-helix transition in the structure of multidrug regulator AcrR at the entrance of the drug-binding cavity[J]. J Struct Biol, 2016, 194(1):18-28.
|
[30] |
WATANABE R, DOUKYU N. Contributions of mutations in acrR and marR genes to organic solvent tolerance in Escherichia coli[J]. AMB Expr, 2012, 2(1):58.
|
[31] |
BLAIR J M A, SMITH H E, RICCI V, et al. Expression of homologous RND efflux pump genes is dependent upon AcrB expression:implications for efflux and virulence inhibitor design[J]. J Antimicrob Chemother, 2015, 70(2):424-431.
|
[32] |
ZHANG C Z, CHEN P X, YANG L, et al. Coordinated expression of acrAB-tolC and eight other functional efflux pumps through activating ramA and marA in Salmonella enterica serovar typhimurium[J]. Microb Drug Resist, 2017, 24(2):120-125.
|
[33] |
SHAMSA F, OHTSUKI K, HASANZADEH E, et al. The anti-inflammatory and anti-viral effects of an ethnic medicine:Glycyrrhizin[J]. J Med Plants Res, 2010, 9(S6):1-28.
|
[34] |
RAHMAN S, SULTANA S. Glycyrrhizin exhibits potential chemopreventive activity on 12-O-tetradecanoyl phorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in swiss albino mice[J]. J Enzym Inhib Med Chem, 2007, 22(3):363-369.
|